NO952660L - Nye benzopyranforbindelser, deres fremstilling og farmasöytiske preparater inneholdene dem - Google Patents
Nye benzopyranforbindelser, deres fremstilling og farmasöytiske preparater inneholdene demInfo
- Publication number
- NO952660L NO952660L NO952660A NO952660A NO952660L NO 952660 L NO952660 L NO 952660L NO 952660 A NO952660 A NO 952660A NO 952660 A NO952660 A NO 952660A NO 952660 L NO952660 L NO 952660L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- halo
- alkoxy
- hydroxy
- preparation
- Prior art date
Links
- 150000001562 benzopyrans Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- -1 pyridinecarbonyl Chemical group 0.000 abstract 7
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 2
- 125000004442 acylamino group Chemical group 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000005185 naphthylcarbonyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 abstract 1
- 125000005544 phthalimido group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9408328A FR2722194B1 (fr) | 1994-07-06 | 1994-07-06 | Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO952660D0 NO952660D0 (no) | 1995-07-05 |
| NO952660L true NO952660L (no) | 1996-01-08 |
| NO311085B1 NO311085B1 (no) | 2001-10-08 |
Family
ID=9465049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19952660A NO311085B1 (no) | 1994-07-06 | 1995-07-05 | Nye benzopyranforbindelser, deres fremstilling og farmasöytiske sammensetninger inneholdene dem |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5663191A (no) |
| EP (1) | EP0691342B1 (no) |
| JP (1) | JP2999139B2 (no) |
| CN (1) | CN1049660C (no) |
| AT (1) | ATE179421T1 (no) |
| AU (1) | AU684165B2 (no) |
| CA (1) | CA2153195C (no) |
| DE (1) | DE69509308T2 (no) |
| DK (1) | DK0691342T3 (no) |
| ES (1) | ES2133686T3 (no) |
| FI (1) | FI111945B (no) |
| FR (1) | FR2722194B1 (no) |
| GR (1) | GR3030168T3 (no) |
| NO (1) | NO311085B1 (no) |
| NZ (1) | NZ272501A (no) |
| ZA (1) | ZA955631B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891882A (en) * | 1996-12-06 | 1999-04-06 | Abbott Laboratories | Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds |
| FR2764890B1 (fr) * | 1997-06-24 | 1999-08-27 | Adir | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5919802A (en) * | 1997-12-05 | 1999-07-06 | Princeton University | Methods of preventing and/or treating temporal lobe epilepsy |
| TWI274750B (en) | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| FR2823752B1 (fr) * | 2001-04-18 | 2004-10-22 | Servier Lab | Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0118892D0 (en) * | 2001-08-02 | 2001-09-26 | Vernalis Res Ltd | Method of treatment |
| US20040053968A1 (en) * | 2001-12-28 | 2004-03-18 | Hartman George D. | Methods and compositions for treating peridontal disease |
| EP1856126A2 (en) * | 2005-02-17 | 2007-11-21 | Wyeth a Corporation of the State of Delaware | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| MX2008012566A (es) * | 2006-04-03 | 2008-10-10 | Hoffmann La Roche | Proceso para preparar acidos beta-aril o heteroaril-carboxilicos ciclicos enantiomericamente enriquecidos. |
| TW200924752A (en) * | 2007-09-17 | 2009-06-16 | Organon Nv | Tricyclic heterocyclic derivatives |
| CN102245570A (zh) * | 2008-12-16 | 2011-11-16 | 弗·哈夫曼-拉罗切有限公司 | 制备吡咯烷-3-甲酸类的方法 |
| FR2948372B1 (fr) * | 2009-07-21 | 2011-07-22 | Servier Lab | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN105111220A (zh) * | 2015-09-12 | 2015-12-02 | 浙江大学 | 取代1,4-二氢苯并吡喃[2,3-b]吡咯化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3518272A (en) * | 1968-02-05 | 1970-06-30 | Warner Lambert Pharmaceutical | Tetrahydro benzopyranoquinolines and process for their production |
| US3888946A (en) * | 1971-03-17 | 1975-06-10 | Little Inc A | Pyrano benzopyrans |
| AU560459B2 (en) * | 1982-06-01 | 1987-04-09 | Abbott Laboratories | Tetrahydro-benzo(e) isoindolines |
| US4666916A (en) * | 1985-11-08 | 1987-05-19 | Ciba-Geigy Corporation | Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents |
| JPH03502701A (ja) * | 1988-12-15 | 1991-06-20 | アボツト・ラボラトリーズ | 5‐ht選択性物質 |
| GB8917333D0 (en) * | 1989-07-28 | 1989-09-13 | Merck Sharp & Dohme | Therapeutic agents |
| FR2687146B1 (fr) * | 1992-02-12 | 1994-04-01 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1994
- 1994-07-06 FR FR9408328A patent/FR2722194B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-04 AU AU24826/95A patent/AU684165B2/en not_active Ceased
- 1995-07-04 CA CA002153195A patent/CA2153195C/fr not_active Expired - Fee Related
- 1995-07-05 EP EP95401607A patent/EP0691342B1/fr not_active Expired - Lifetime
- 1995-07-05 US US08/498,217 patent/US5663191A/en not_active Expired - Lifetime
- 1995-07-05 NO NO19952660A patent/NO311085B1/no not_active IP Right Cessation
- 1995-07-05 AT AT95401607T patent/ATE179421T1/de active
- 1995-07-05 FI FI953308A patent/FI111945B/fi not_active IP Right Cessation
- 1995-07-05 DK DK95401607T patent/DK0691342T3/da active
- 1995-07-05 ES ES95401607T patent/ES2133686T3/es not_active Expired - Lifetime
- 1995-07-05 DE DE69509308T patent/DE69509308T2/de not_active Expired - Lifetime
- 1995-07-05 NZ NZ272501A patent/NZ272501A/en not_active IP Right Cessation
- 1995-07-05 CN CN95109942A patent/CN1049660C/zh not_active Expired - Fee Related
- 1995-07-06 JP JP7170635A patent/JP2999139B2/ja not_active Expired - Fee Related
- 1995-07-06 ZA ZA955631A patent/ZA955631B/xx unknown
-
1997
- 1997-01-21 US US08/786,504 patent/US5723484A/en not_active Expired - Lifetime
-
1999
- 1999-05-07 GR GR990401249T patent/GR3030168T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI111945B (fi) | 2003-10-15 |
| DE69509308T2 (de) | 1999-11-25 |
| CN1119189A (zh) | 1996-03-27 |
| DE69509308D1 (de) | 1999-06-02 |
| CA2153195A1 (fr) | 1996-01-07 |
| ATE179421T1 (de) | 1999-05-15 |
| FR2722194A1 (fr) | 1996-01-12 |
| FI953308A7 (fi) | 1996-01-07 |
| DK0691342T3 (da) | 1999-11-08 |
| ZA955631B (en) | 1996-02-16 |
| AU2482695A (en) | 1996-01-18 |
| EP0691342B1 (fr) | 1999-04-28 |
| GR3030168T3 (en) | 1999-08-31 |
| ES2133686T3 (es) | 1999-09-16 |
| AU684165B2 (en) | 1997-12-04 |
| CA2153195C (fr) | 2004-06-15 |
| US5663191A (en) | 1997-09-02 |
| CN1049660C (zh) | 2000-02-23 |
| FI953308A0 (fi) | 1995-07-05 |
| JP2999139B2 (ja) | 2000-01-17 |
| NO952660D0 (no) | 1995-07-05 |
| NO311085B1 (no) | 2001-10-08 |
| EP0691342A1 (fr) | 1996-01-10 |
| FR2722194B1 (fr) | 1996-08-23 |
| US5723484A (en) | 1998-03-03 |
| NZ272501A (en) | 1996-03-26 |
| JPH0841066A (ja) | 1996-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952660D0 (no) | Nye benzopyranforbindelser, deres fremstilling og farmasöytiske preparater inneholdene dem | |
| EP0767170A4 (en) | Novel 4,6-diarylpyrimidine derivatives and salts thereof | |
| TR199902995T2 (xx) | 9-Oksim eritromisin t�revleri | |
| LU90677I2 (fr) | Esomeprazole et ses sels et d-riv-s pharmaceutiquement acceptables (nexiam) | |
| MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
| DK0580502T3 (da) | 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse | |
| EA200100983A1 (ru) | Производные 13-метилэритромицина | |
| EP0765865A4 (en) | 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION | |
| UA50711C2 (uk) | Антрациклінові похідні, їх застосування при лікуванні амілоїдозу та фармацевтична композиція | |
| DK0992509T3 (da) | Nye makrolid-derivater | |
| IL148875A0 (en) | Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them | |
| BG103426A (en) | Derivatives of substituted 4-biphenyl-4-hydroxy-oil acids as inhibitors of matrix metalloproteases | |
| NO930143L (no) | Piperidinforbindelser, deres fremstilling og bruk | |
| DK0669331T3 (da) | Benzodioxanderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem | |
| DK160686A (da) | Tri- og tetracycliske forbindelser | |
| IL112102A0 (en) | Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| TW347389B (en) | Taxoids, their preparation and pharmaceutical compositions containing them | |
| DK0564358T3 (da) | 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne | |
| FR2596760B1 (fr) | Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique | |
| AR241021A2 (es) | Un proceso de preparacion de nuevos derivados de 5-(omega-fenitilamialquil)-4,5,6,7-tetrahidro-tieno-(3, 2-c)-piridina" | |
| NO972943L (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse | |
| IL61911A (en) | 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them | |
| ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| NO306300B1 (no) | 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |